Pharmaceutical company Haleon has voluntarily recalled eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult cough syrups at the consumer level due to potential microbial contamination. The recall comes amidst concerns that immunocompromised individuals using the affected product may face severe or life-threatening adverse events, such as fungemia or disseminated fungal infection.
While non-immunocompromised consumers are not likely to experience life-threatening infections, the recall emphasizes the possibility of infections necessitating medical intervention. Haleon assures that, to date, no adverse events related to this recall have been reported.
Consumers who have purchased the recalled product are urged to cease consumption immediately. Haleon is actively notifying distributors and customers and providing instructions for the return of the affected cough syrups. Adverse reactions or quality problems can be reported to the FDA’s MedWatch Adverse Event Reporting program online or through regular mail or fax.
Reporting for WGRT – Choze Powell
